BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Aug. 6, 2010
View Archived Issues
GSK to develop Anacor's new antibiotic for Gram-negative infections
Read More
Bristol-Myers Squibb claims new JAK2 inhibitors
Read More
Santhera discloses new MC4 receptor antagonists
Read More
New FPS inhibitors discovered at Novartis
Read More
Dr. Reddy's Laboratories and Pulmagen Therapeutics claim new PPAR-gamma agonists
Read More
CANOE trial data support use of Avandamet to prevent type 2 diabetes
Read More
Scientists report regional changes in brain gray matter density in patients with IBS
Read More
PF-3845 has antiallodynic effects in preclinical study
Read More
Scientists explore neuroprotective role of URB-597 in models of retinal neurodegeneration
Read More
Preclinical study implicates GPR55 in regulation of osteoclast number and function
Read More
Telormedix and Swiss TPH join to study TMX-201 in malaria and Buruli ulcer
Read More
TapImmune and Mayo Clinic partner to develop smallpox vaccine technology
Read More
FDA issues complete response letter for Luveniq NDA in noninfectious uveitis
Read More
Gemin X secures funding for obatoclax development
Read More
Resolor approved in Switzerland for idiopathic chronic constipation
Read More
FDA accepts NDA for gadobutrol injection in MRI of CNS
Read More
BrainCells acquires Proximagen's sabcomeline for major depressive disorder
Read More
Affymax and Takeda outline U.S. registration strategy for Hematide
Read More
FDA approves new docetaxel injection concentrate formulation for cancer
Read More
YM concludes dose escalation in phase I CYT-387 trial in myelofibrosis
Read More
EMA's CHMP issues positive opinion on Relistor in prefilled syringes
Read More
Vicept presents clinical data on V-101 in rosacea-associated erythema
Read More
NIH provides grant for phase I/II AEZS-108 trial in advanced prostate cancer
Read More
Tekmira files IND application with FDA for PLK1-SNALP in solid tumors
Read More
Takeda presents new glucokinase activators
Read More